Clinical Trial Update: Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update on weekly combination therapy with carfilzomib, cyclophosphamide, and dexamethasone (wCCyd) in newly diagnosed multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED